Adage Capital Partners Gp, L.L.C. Abeona Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,691,628 shares of ABEO stock, worth $16.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,691,628
Previous 3,902,360
31.03%
Holding current value
$16.8 Million
Previous $21.7 Million
40.84%
% of portfolio
0.02%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding ABEO
# of Institutions
83Shares Held
28.1MCall Options Held
556KPut Options Held
34.9K-
Suvretta Capital Management, LLC New York, NY3.69MShares$23 Million0.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.51MShares$21.9 Million0.75% of portfolio
-
Western Standard LLC Los Angeles, CA2.28MShares$14.2 Million6.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$12.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$11.5 Million2.38% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $37.1M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...